WO2004092222A2 - Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; - Google Patents
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; Download PDFInfo
- Publication number
- WO2004092222A2 WO2004092222A2 PCT/FR2004/000870 FR2004000870W WO2004092222A2 WO 2004092222 A2 WO2004092222 A2 WO 2004092222A2 FR 2004000870 W FR2004000870 W FR 2004000870W WO 2004092222 A2 WO2004092222 A2 WO 2004092222A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- advantageously
- polymer
- molecular weight
- crosslinking
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Definitions
- the subject of the present invention is:
- hydrogels in question based on said crosslinked polymers, have numerous outlets, in particular as filling material in restorative, aesthetic, dental surgeries, in ophthalmology, in orthopedics ... as a product preventing tissue adhesions, in general surgery, urology ... Said hydrogels are particularly suitable for repairing the vocal cords.
- outlets indicated above, in a nonlimiting manner, for this type of product, are familiar to those skilled in the art.
- the invention results from a real effort to optimize the implementation of the crosslinking of the polymers in question, with a view to obtaining injectable monophasic hydrogels, which are particularly advantageous with reference to the compromise below: mechanical properties and persistence, on the one hand, injectability (with injection forces and acceptable injection needle diameters), on the other hand.
- compositions With reference to the specific problem of injectability, two-phase compositions have been proposed, the continuous phase of which in particular is based on such hydrogels. Said continuous phase serves as a plasticizer, as an injection vehicle for a dispersed phase. This dispersed phase is more or less solid, more or less differentiated from the continuous phase. So :
- the biphasic compositions described consist of two phases - continuous, dispersed - bioresorbable and are in the form of sludge. Said two phases are advantageously prepared from Hylan fibers (natural hyaluronic acid chemically modified in situ in order to facilitate its extraction from the tissues), - in application WO-A-96 337 51, the biphasic compositions described also have two bioresorbable phases, better separated, the dispersed phase consisting of insoluble fragments of a polymer hydrogel (chosen from hyaluronic acid and its salts), highly crosslinked; - In application WO-A-00 014 28, the biphasic compositions described contain a dispersed phase, not bioresorbable (particles of at least one hydrogel of a (co) polymer obtained by polymerization and crosslinking of acrylic acid and / or methacrylic acid and / or at least one derivative of said acids), in suspension in an aqueous solution
- the product in question is not an injectable hydrogel but a product of solid consistency.
- eye implants are in fact described, used to temporarily fill a vacuum created surgically.
- the hydrogel produced is proposed as a substitute for the vitreous body.
- the polymer in question sodium hyaluronate
- the monophasic hydrogel described is charged with an antiseptic, effective to protect it, after implantation, against free radicals.
- WO-A-02 063 50 a process is described, capable of generating this type of hydrogel, very homogeneous in its mass.
- All these monophasic hydrogels were obtained from polymers of high molecular mass, crosslinked with the intervention of an effective and not excessive amount of at least one crosslinking agent, in aqueous solvent.
- the inventors wished to improve the efficiency of the crosslinking of the polymer in question so as in particular to improve the resistance to degradation (the persistence) of the implanted hydrogel, while retaining the possibility of injecting said hydrogel under acceptable conditions.
- the inventors first thought of involving more crosslinking agent. This approach was quickly discarded insofar as it inevitably leads to denaturation of the polymer in question and chemical pollution of the crosslinked product obtained. Said inventors then thought of increasing the concentration of polymer in the reaction mixture.
- the inventors have surprisingly established that by combining low molecular weight polymer (s) and high molecular weight polymer (s), an excellent compromise is obtained, namely the possibility of generating, for a non-excessive crosslinking rate (equivalent to that of the prior art) a monophasic, injectable hydrogel with improved mechanical properties and remanence.
- This low mass / high mass association makes it possible to obtain a hydrogel which more than satisfactorily meets the following specifications: - monophasic,
- the key factor of the crosslinking process of the invention therefore resides in the concentration of the reagents (which is increased compared to that of the reaction mixtures of the prior art, due to the intervention of low molecular weight polymer (s). ), the crosslinking of said concentrated reagents being however "controlled” by the intervention of polymer (s) of high molecular weight, which guarantee the homogeneity of the crosslinked product and then of the hydrogel obtained.
- the present invention therefore relates to a process for crosslinking at least one polymer chosen from polysaccharides and their derivatives, used in aqueous solvent by action of an effective and not excessive amount of at least one crosslinking agent, improved in that it is used on a mixture containing at least one low molecular weight polymer and at least one high molecular weight polymer.
- Said mixture naturally includes the said (s) polymer (s) of low molecular weight in sufficient quantity to guarantee a relatively high concentration of the reaction medium in polymer (s) and the said (s) polymer (s) ) of high molecular mass in an amount sufficient to guarantee a homogeneous consistency to said crosslinked polymer obtained.
- Examples of synthetic derivatives of natural polysaccharides are carboxyoixose, carboxymethylcellutose, alkylcelluloses, such as hydroxyethylcellulose, hydroxypropylmethylcellulose (HPMC) , oxidized starch ...
- the process of the invention is likely to be suitable for the crosslinking of any one of these polymers, insofar as said polymer intervenes at low (s) and high (s) molecular weights.
- the process of the invention is likely to be suitable for the crosslinking of mixtures of such polymers, said mixtures containing at least one low molecular weight polymer and at least one high molecular weight mixture.
- the reaction medium contains a single polymer, which is involved in at least two differentiated molecular weights: at least one weak and at least one strong.
- the same polymer is preferably used at a single low molecular weight and at a single high molecular weight.
- the polymer in question is advantageously a salt of hyaluronic acid. It is very advantageously chosen from the sodium salt, the potassium salt and their mixtures. It preferably consists of the sodium salt (NaHA).
- crosslinking of this type of polymer a person skilled in the art understands that said crosslinking is carried out in a basic aqueous solvent. In general, said crosslinking is obviously carried out under pH conditions favorable to the dissolution of the polymer in question.
- reaction mixture contains:
- said reaction mixture advantageously has an intrinsic viscosity of less than 1,900 ml / g, ie
- the reaction mixture advantageously contains more than 50%, very advantageously more than 70%, by mass of at least one salt of hyaluronic acid of low molecular mass m and therefore, logically, advantageously less than 50%, very advantageously less than 30%, by mass of at least one salt of hyaluronic acid of high molecular mass M.
- crosslinking method of the invention is advantageously implemented with the sodium salt of hyaluronic acid, intervening at a low molecular mass m and at a high molecular mass M. We then very advantageously have: m ⁇ 3.10 5 Da and M ⁇ 3.10 6 Da.
- crosslinking agent with all types of polymer, any agent known to crosslink polysaccharides and their derivatives can be used, via its hydroxyl functions - crosslinking agent at least bifunctional, to ensure crosslinking - and in particular an epoxy or its derivatives. We recommend the intervention of crosslinking agents, bifunctional, alone or in mixture.
- crosslinking agent s
- ⁇ crosslinking rate
- ⁇ _ Total number of reactive functions of said crosslinking agent ⁇ ⁇ QQ Total number of disaccharide units of the polymer molecules between 0.5 and 70%, advantageously between 4 and 50%.
- crosslinking process of the invention is original due to the forms of intervention of the polymers in question. Otherwise, it is implemented in a conventional manner with at least one crosslinking agent. It is noted that said crosslinking agent is generally reacted on the dissolved polymer (s). It is however in no way excluded that it intervenes on the said polymer (s) during hydration, according to the process described in WO-A-02 06 350.
- the crosslink obtained at the end of the implementation of the crosslinking process of the invention is generally formulated to generate the desired injectable monophasic hydrogel. It is if necessary neutralized beforehand.
- the formulation is implemented in a buffered solution at a pH compatible with the human body (since the hydrogel in question is generally intended for injection into the human body): pH between 6.5 and 7.5 advantageously between 7 and 7.4, very advantageously between 7.1 and 7.3.
- the crosslinked polymer equilibrates. It also acquires an osmolarity compatible with that of the human body ...
- the crosslinked polymers of the invention diluted are monophasic hydrogels.
- an injectable hydrogel of the invention is prepared, by crosslinking a mixture of at least one polymer, salt (s) of hyaluronic acid (see above), by neutralizing the reticulate obtained, then by formulating it in a buffered solution at a pH between 7.1 and 7.3, at a concentration between 10 and 40 mg / g, advantageously between 20 and 30 mg / g.
- the process for preparing the injectable monophasic hydrogel from the crosslinked polymer constitutes the second object of the present invention.
- Said polymer and hydrogel advantageously contain low molecular weight sodium hyaluronate and high molecular weight sodium hyaluronate; said low molecular weight sodium hyaluronate very advantageously occurring at more than 50% by mass.
- the structure of the injectable monophasic hydrogel - fourth object of the present invention - is original. Its consistency resists degradation. This resistance of the hydrogel is much higher than that of equivalent products of the prior art.
- hydrogels of the invention have the outlets indicated in the introduction to this text. They are particularly effective there. It is now proposed to illustrate the invention in its various aspects, by the examples below. More precisely, we have:
- Example 1 which illustrates the prior art (crosslinking of a high molecular weight polymer)
- Example 2 which illustrates the remarks made in the introduction to this text (crosslinking of the same low molecular weight polymer)
- the intrinsic viscosity of sodium hyaluronate (NaHA) (in ml / g) is determined in accordance with the European Pharmacopoeia of NaHA (2.2.9), by a capillary viscometer of Ubelhode type.
- the injectability of the NaHA-based gel is determined by measuring the force required (in Newton, N) to eject the gel contained in a standard syringe, through a 27 GVz needle, at a speed of 12.5 mm / min. The tests were carried out on a Verstatet ® traction device sold by the company Mecmésin.
- the consistency of the gel is characterized at 25 ° C. by a rheological measurement of the elastic (G 1 ) and viscous (G ") modules as a function of the frequency (from 0.05 to 10 Hz) and in the fields of constant deformation, at using a constrained constraint rheometer (Carrimed CSL 500 from TA Instruments) and a cone / plane geometry 4 cm 2 ° This rheometer is checked and calibrated regularly
- the gels are degraded by being brought to the temperature of 93 °. vs.
- Macroscopic aspect flexible and continuous
- Macroscopic aspect "puree" which fragments very easily - no cohesion of the gel nor of shooting aspect.
- NaHA sodium hyaluronate fibers
- the reaction lasts 2 h.
- [NaHA] f NaHA concentration in the final hydrogel after reaction and dilution with a quantity qs of phosphate buffer
- hydrogels of the invention (examples 3 and 4) have a rheological behavior different from that of the hydrogel of the prior art (example 1).
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006505785A JP4827727B2 (ja) | 2003-04-10 | 2004-04-08 | 低分子量及び高分子量の多糖の架橋;注射用単相ヒドロゲルの調製;多糖及び得られたヒドロゲル |
US10/552,309 US7741476B2 (en) | 2003-04-10 | 2004-04-08 | Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and hydrogels thus obtained |
EP04742458A EP1611160A2 (fr) | 2003-04-10 | 2004-04-08 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
BRPI0409762-9A BRPI0409762B1 (pt) | 2003-04-10 | 2004-04-08 | Processo para preparar um polímero reticulado e processo para preparar um hidrogel monofásico injetável |
CA2521961A CA2521961C (fr) | 2003-04-10 | 2004-04-08 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
US12/782,488 US8338388B2 (en) | 2003-04-10 | 2010-05-18 | Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained |
US13/566,767 US8563532B2 (en) | 2003-04-10 | 2012-08-03 | Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained |
US14/024,916 US9062130B2 (en) | 2003-04-10 | 2013-09-12 | Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained |
US14/535,220 US20150065701A1 (en) | 2003-04-10 | 2014-11-06 | Injectable monophase hydrogels |
US15/209,561 US10080767B2 (en) | 2003-04-10 | 2016-07-13 | Injectable monophase hydrogels |
US16/137,447 US10653716B2 (en) | 2003-04-10 | 2018-09-20 | Injectable monophase hydrogels |
US16/856,029 US11045490B2 (en) | 2003-04-10 | 2020-04-23 | Injectable monophase hydrogels |
US17/361,195 US20210322460A1 (en) | 2003-04-10 | 2021-06-28 | Injectable monophase hydrogels |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0304444A FR2861734B1 (fr) | 2003-04-10 | 2003-04-10 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
FR0304444 | 2003-04-10 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10552309 A-371-Of-International | 2004-04-08 | ||
US10/552,309 A-371-Of-International US7741476B2 (en) | 2003-04-10 | 2004-04-08 | Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and hydrogels thus obtained |
US12/782,488 Division US8338388B2 (en) | 2003-04-10 | 2010-05-18 | Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004092222A2 true WO2004092222A2 (fr) | 2004-10-28 |
WO2004092222A3 WO2004092222A3 (fr) | 2004-12-09 |
Family
ID=33186443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2004/000870 WO2004092222A2 (fr) | 2003-04-10 | 2004-04-08 | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
Country Status (8)
Country | Link |
---|---|
US (9) | US7741476B2 (fr) |
EP (3) | EP2289945B1 (fr) |
JP (1) | JP4827727B2 (fr) |
BR (1) | BRPI0409762B1 (fr) |
CA (1) | CA2521961C (fr) |
ES (1) | ES2536564T3 (fr) |
FR (1) | FR2861734B1 (fr) |
WO (1) | WO2004092222A2 (fr) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2423252A (en) * | 2005-02-18 | 2006-08-23 | Engelhard Lyon | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
FR2909560A1 (fr) * | 2006-12-06 | 2008-06-13 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
JP2009536625A (ja) * | 2006-05-11 | 2009-10-15 | ゴッボ・サンドラ | ヒアルロン酸二成分混合物、その医療での使用 |
WO2010052430A2 (fr) | 2008-11-07 | 2010-05-14 | Anteis S.A. | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaïne, sterilisee a la chaleur |
EP2289522A1 (fr) * | 2009-08-14 | 2011-03-02 | Holy Stone Healthcare Co.,Ltd. | Utilisation d'acide hyaluronique pour le traitement d'ulcers gastro-duodenaux |
ES2362587A1 (es) * | 2009-12-24 | 2011-07-08 | Laboratorios Viñas S.A. | "toallita impregnada con una composición farmacéutica que comprende acido hialurónico, composición farmacéutica que comprende ácido hialurónico y usos correspondientes.". |
EP2404619A1 (fr) * | 2010-07-05 | 2012-01-11 | Alain Villette | Composition injectable comprenant un médicament injectable et un gel |
ITMI20101635A1 (it) * | 2010-09-09 | 2012-03-10 | Ibsa Inst Biochimique Sa | Complessi cooperativi ibridi di acido ialuronico |
WO2010115081A3 (fr) * | 2009-04-02 | 2012-04-12 | Allergan, Inc. | Hydrogels en forme de cheveu pour augmentation des tissus mous |
WO2013053457A1 (fr) | 2011-10-12 | 2013-04-18 | Regenyal Laboratories S.R.L. | Synthèse d'un gel multiphasique injectable contenant de l'acide hyaluronique monophasique libre et réticulé et de l'acide hyaluronique biphasique en association avec de l'hydroxyapatite et un inhibiteur de l'hyaluronidase microencapsulé |
US8524213B2 (en) | 2003-12-30 | 2013-09-03 | Genzyme Corporation | Polymeric materials, their preparation and use |
US8574629B2 (en) | 2008-08-01 | 2013-11-05 | Anteis S.A. | Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume |
US9133279B2 (en) | 2005-02-18 | 2015-09-15 | Basf Beauty Care Solutions France S.A.S. | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
US9155757B2 (en) | 2013-10-07 | 2015-10-13 | Laboratoires Vivacy | Methods and kits for treating vaginal and vulvar vestibule mucosa disorders |
US9228027B2 (en) | 2008-09-02 | 2016-01-05 | Allergan Holdings France S.A.S. | Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US9314530B2 (en) | 2012-06-13 | 2016-04-19 | Laboratoires Vivacy | Composition, in aqueous medium, that comprises at least a hyaluronic acid and at least an hydrosoluble salt of sucrose octasulfate |
US9402799B2 (en) | 2012-08-29 | 2016-08-02 | Laboratories Vivacy | Sterilized composition comprising at least one hyaluronic acid and magnesium ascorbyl phosphate |
WO2016180904A1 (fr) | 2015-05-11 | 2016-11-17 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
EP2637710B1 (fr) | 2010-11-08 | 2017-04-05 | Allergan Industrie, SAS | Formulations à base d'acide hyaluronique |
EP3173086A1 (fr) | 2013-12-23 | 2017-05-31 | Laboratoires Vivacy | Compositions d'acide hyaluronique comprenant de la mépivacaïne |
WO2017098091A1 (fr) | 2015-12-07 | 2017-06-15 | Tauzin Bénédicte Vincente | Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition |
WO2017102001A1 (fr) | 2015-12-16 | 2017-06-22 | Vplus International Sa | Composition d'acide hyaluronique pour injections peniennes |
WO2017140958A1 (fr) | 2016-02-15 | 2017-08-24 | Tauzin Bénédicte Vincente | Composition injectable; procédé de préparation de ladite composition; utilisation de ladite composition |
EP3007737B1 (fr) | 2013-06-11 | 2017-10-18 | Anteis SA | Procédé de réticulation de l'acide hyaluronique, procédé de préparation d'un hydrogel injectable, hydrogel obtenu et utilisation de l'hydrogel obtenu |
US9919076B2 (en) | 2007-12-07 | 2018-03-20 | Laboratoires Vivacy | Biodegradable single-phase cohesive hydrogels |
EP3315130A1 (fr) | 2016-10-28 | 2018-05-02 | Laboratoires Vivacy | Composition a base d'acide hyaluronique comprenant de la mepivacaïne |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
WO2018220283A1 (fr) | 2017-05-29 | 2018-12-06 | Kh Medtech Sarl | Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine |
US10328180B2 (en) | 2008-08-04 | 2019-06-25 | Allergan Industrie, S.A.S. | Hyaluronic acid-based gels including lidocaine |
US10588922B2 (en) | 2015-06-24 | 2020-03-17 | Kylane Laboratoires Sa | Method for preparing an injectable cross-linked hydrogel, hydrogel obtained; and use of the obtained hydrogel |
WO2021260145A1 (fr) | 2020-06-24 | 2021-12-30 | Laboratoires Vivacy | Procede d'incorporation de composes organiques en solution au sein d'un hydrogel |
WO2022038156A1 (fr) | 2020-08-20 | 2022-02-24 | Laboratoires Vivacy | Procede d'evaluation des caracteristiques rheologiques d'un gel |
US11260015B2 (en) | 2015-02-09 | 2022-03-01 | Allergan Industrie, Sas | Compositions and methods for improving skin appearance |
WO2023187131A1 (fr) | 2022-03-30 | 2023-10-05 | Laboratoires Vivacy | Emulsion comprenant un hydrogel et de la graisse ou un derive de graisse |
Families Citing this family (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
EP1553878B1 (fr) | 2002-08-28 | 2010-02-24 | Allergan, Inc. | Dispositif de cerclage gastrique resistant a l'usure |
FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
JP2007527279A (ja) | 2004-01-23 | 2007-09-27 | アラーガン、インコーポレイテッド | 取り外し可能に固定できるワンピース調整可能な胃バンド |
ATE444045T1 (de) | 2004-03-08 | 2009-10-15 | Allergan Medical S A | Verschlusssystem für röhrenförmige organe |
WO2005094257A2 (fr) | 2004-03-18 | 2005-10-13 | Inamed Medical Products Corporation | Appareil et procede de reglage du volume de ballons intragastriques |
US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
ITTO20040918A1 (it) * | 2004-12-29 | 2005-03-29 | Luigi Ambrosio | Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
US7798954B2 (en) * | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
CA2687990A1 (fr) * | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Collagene reticule et utilisations de ce dernier |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US20120071437A1 (en) | 2007-07-30 | 2012-03-22 | Allergan, Inc. | Tunable crosslinked polysaccharide compositions |
US20110077737A1 (en) * | 2007-07-30 | 2011-03-31 | Allergan, Inc. | Tunably Crosslinked Polysaccharide Compositions |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
SI2818184T1 (sl) | 2007-11-16 | 2019-03-29 | Aclaris Therapeutics, Inc. | Sestava in postopki za zdravljenje purpure |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
EP2219679A1 (fr) * | 2007-12-21 | 2010-08-25 | Encecor AB | Hydrogel réticulé contenant une substance active |
US8668863B2 (en) * | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
AU2015252122A1 (en) * | 2008-08-04 | 2015-11-26 | Allergan Industrie Sas | Hyaluronic acid-based gels including anesthetic agents |
US20130102563A1 (en) * | 2008-08-04 | 2013-04-25 | Allergan, Inc. | Dermal filler with lidocaine |
WO2010027471A2 (fr) | 2008-09-04 | 2010-03-11 | The General Hospital Corporation | Hydrogels pour l'augmentation et la réparation des cordes vocales et de tissu mou |
US20100305397A1 (en) * | 2008-10-06 | 2010-12-02 | Allergan Medical Sarl | Hydraulic-mechanical gastric band |
WO2010042493A1 (fr) | 2008-10-06 | 2010-04-15 | Allergan, Inc. | Bande gastrique mécanique avec coussins |
US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
JP4885245B2 (ja) * | 2009-01-15 | 2012-02-29 | 日本航空電子工業株式会社 | Rdコンバータ及び角度検出装置 |
EP2236523B1 (fr) | 2009-03-30 | 2018-02-21 | Scivision Biotech Inc. | Procédé de production d'acide hyaluronique réticulé |
US20100261893A1 (en) * | 2009-04-09 | 2010-10-14 | Scivision Biotech Inc. | Method for producing cross-linked hyaluronic acid |
US9371402B2 (en) | 2009-04-09 | 2016-06-21 | Scivision Biotech Inc. | Method for producing cross-linked hyaluronic acid |
US8390326B2 (en) * | 2009-05-05 | 2013-03-05 | William Marsh Rice University | Method for fabrication of a semiconductor element and structure thereof |
TWI516269B (zh) * | 2009-08-14 | 2016-01-11 | 禾伸堂生技股份有限公司 | 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物 |
US8575130B2 (en) * | 2010-01-04 | 2013-11-05 | Holy Stone Healthcare Co., Ltd. | Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20110171286A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan, Inc. | Hyaluronic acid compositions for dermatological use |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110171310A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
US8840541B2 (en) * | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
WO2011109730A2 (fr) | 2010-03-04 | 2011-09-09 | The General Hospital Corporation | Procédés et systèmes de compensation des déficiences vocales au moyen d'un implant de muqueuse adaptable permettant de rétablir et renforcer la production sonore et vocale humaine individualisée |
CA2792729C (fr) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Composition fluide pour l'amelioration d'etats cutanes |
CA2794254C (fr) * | 2010-03-22 | 2018-09-04 | Allergan, Inc. | Hydrogels reticules a base de polysaccharides et de proteines- polysaccharides pour l'augmentation des tissus mous |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
US8946194B2 (en) | 2010-10-08 | 2015-02-03 | Board Of Regents, University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
EP4169541A1 (fr) | 2010-11-08 | 2023-04-26 | Allergan Industrie, SAS | Charge de tissu mou |
AU2015275313A1 (en) * | 2010-11-08 | 2016-01-21 | Allergan Industrie, Sas | Hyaluronic acid based formulations |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
FR2968305B1 (fr) | 2010-12-06 | 2014-02-28 | Teoxane | Procede de preparation d'un gel reticule |
EP3682911A1 (fr) | 2011-01-13 | 2020-07-22 | Allergan, Inc. | Compositions d'hydrogel stables comprenant des additifs |
AU2012217630A1 (en) | 2011-02-17 | 2013-09-05 | Allergan, Inc. | Compositions and improved soft tissue replacement methods |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
CN103702659B (zh) | 2011-06-03 | 2016-12-21 | 阿勒根公司 | 包括抗氧化剂的皮肤填充剂组合物 |
WO2013028904A2 (fr) | 2011-08-25 | 2013-02-28 | Allergan, Inc. | Compositions de comblement dermique contenant des antioxydants |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
EP2755630A2 (fr) | 2011-09-14 | 2014-07-23 | Allergan, Inc. | Compositions de comblement dermique pour le traitement des ridules |
EP2581079B1 (fr) * | 2011-10-11 | 2016-12-07 | BioPolymer GmbH & Co. KG | Combinaison d'acide hyaluronique et de prilocaïne |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
KR102168028B1 (ko) | 2011-12-08 | 2020-10-20 | 알러간 인더스트리 에스에이에스 | 진피 필러 조성물 |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
SG11201408312UA (en) * | 2012-06-15 | 2015-01-29 | Merz Pharma Gmbh & Co Kgaa | Method of preparing a composition based on hyaluronic acid |
JP6108500B2 (ja) | 2012-07-18 | 2017-04-05 | アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエAllergan Industrie Sas | ピルビン酸塩を含有するヒアルロン酸製剤 |
KR20150061655A (ko) | 2012-10-02 | 2015-06-04 | 알러간, 인코포레이티드 | 비타민 a/시클로덱스트린 포접 복합체를 갖는 진피 충전제 하이드로겔 |
WO2014055895A1 (fr) | 2012-10-05 | 2014-04-10 | Allergan, Inc. | Dispositif injectable et méthode de modelage, d'augmentation ou de correction de traits faciaux tels que du menton |
US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
EP3505197B1 (fr) | 2012-12-11 | 2023-09-06 | Board of Regents, The University of Texas System | Membrane à hydrogel pour la prévention de l'adhérence |
KR102033179B1 (ko) * | 2012-12-28 | 2019-10-16 | 롯데정밀화학 주식회사 | 스킴코트 모르타르용 첨가제 및 이를 포함하는 스킴코트 모르타르 조성물 |
US9492474B2 (en) | 2013-07-10 | 2016-11-15 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
AR099900A1 (es) | 2014-04-01 | 2016-08-24 | Merz Pharma Gmbh & Co Kgaa | Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso |
AR099941A1 (es) | 2014-04-01 | 2016-08-31 | Klox Tech Inc | Composiciones para relleno de tejido y métodos de uso |
US10722444B2 (en) | 2014-09-30 | 2020-07-28 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
FR3029928B1 (fr) | 2014-12-15 | 2018-03-09 | Teoxane | Gel reticule |
JP6759220B2 (ja) | 2015-01-28 | 2020-09-23 | アラーガン、インコーポレイテッドAllergan,Incorporated | 関節脂肪パッド製剤、およびその使用方法 |
EP3653232A1 (fr) * | 2015-02-13 | 2020-05-20 | Allergan Industrie, SAS | Implants pour sculpter, augmenter ou corriger des caractéristiques faciales telles que le menton |
US9737395B2 (en) | 2015-06-26 | 2017-08-22 | Phi Nguyen | Systems and methods for reducing scarring |
US10836840B2 (en) | 2015-06-30 | 2020-11-17 | Merz Pharma Gmbh & Co. Kgaa | Method for producing crosslinked hyaluronic acid |
US10130578B2 (en) | 2015-07-23 | 2018-11-20 | Johnson & Johnson Consumer Inc. | Topical delivery of skin compositions having low pH |
US11021580B2 (en) | 2015-07-27 | 2021-06-01 | Galderma Holding SA | Process for efficient cross-linking of hyaluronic acid |
PL3352766T3 (pl) | 2015-09-24 | 2021-08-02 | Matrix Biology Institute | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
KR20170090965A (ko) * | 2016-01-29 | 2017-08-08 | 한미약품 주식회사 | 복합 히알루론산 가교물 및 그 제조방법 |
IT201600079633A1 (it) * | 2016-07-28 | 2018-01-28 | Fidia Farm Spa | Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico |
KR20190070343A (ko) | 2016-10-13 | 2019-06-20 | 알레간 인코포레이티드 | 피부 필러 응용을 위한 코아세르베이트 하이알루로난 하이드로겔 |
US10660419B2 (en) * | 2016-12-15 | 2020-05-26 | Elc Management Llc | Packaged skin treatment composition and method |
US11980700B2 (en) | 2017-03-08 | 2024-05-14 | Alafair Biosciences, Inc. | Hydrogel medium for the storage and preservation of tissue |
CN108250462A (zh) * | 2017-05-08 | 2018-07-06 | 上海利康瑞生物工程有限公司 | 一种抗酶解交联透明质酸钠凝胶及其制备方法和制剂 |
JP6912327B2 (ja) | 2017-09-04 | 2021-08-04 | 大日精化工業株式会社 | 医療用・美容材料の製造方法及び医療用・美容材料 |
CN107802597B (zh) * | 2017-12-08 | 2020-07-31 | 北京诺康达医药科技股份有限公司 | 一种玻璃酸钠组合物及其制备方法和应用 |
JP2021522926A (ja) | 2018-05-09 | 2021-09-02 | ザ ジョンズ ホプキンス ユニバーシティ | 軟組織の補填及び再生の増強のためのナノファイバー−ハイドロゲル複合体 |
EP3790602A1 (fr) | 2018-05-09 | 2021-03-17 | The Johns Hopkins University | Composites nanofibres-hydrogel pour l'administration de cellules et de tissus |
KR20210041562A (ko) | 2018-08-07 | 2021-04-15 | 메르츠 파마 게엠베하 운트 코. 카가아 | 가교된 하이드로겔의 동적 여과 방법 |
IT201900021693A1 (it) * | 2019-11-20 | 2021-05-20 | Bmg Pharma S P A | Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione |
JP2023523028A (ja) * | 2020-04-23 | 2023-06-01 | プレリオン セラピューティクス (シェンチェン) リミテッド | 生体適合性材料並びにその作製及び使用方法 |
KR102430642B1 (ko) * | 2020-07-03 | 2022-08-16 | 주식회사 메피온 | 필러 조성물 및 그 제조 방법 |
CN112940304B (zh) * | 2021-03-16 | 2023-02-28 | 杭州基智生物科技有限公司 | 一种三维细胞培养支架、成纤维细胞凝胶及其制备方法 |
WO2023135135A1 (fr) * | 2022-01-11 | 2023-07-20 | Gpq S.R.L. | Nouveaux dérivés d'acides hyaluroniques en tant que combleurs innovants |
CN114409929B (zh) * | 2022-02-07 | 2024-07-05 | 南京易亨制药有限公司 | 一种聚合物水凝胶及其制备方法和其应用 |
CN116082713B (zh) * | 2022-12-06 | 2024-03-01 | 浙江工业大学 | 一种pH/温度双重响应智能水凝胶及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA949965A (en) * | 1971-12-03 | 1974-06-25 | Robert H. Marchessault | Method of preparing cross-linked starch and starch derivatives |
US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US4886787A (en) * | 1984-07-23 | 1989-12-12 | Pharmacia Ab | Method of preventing adhesion between body tissues, means for preventing such adhesion, and process for producing said means |
US5531716A (en) * | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
Family Cites Families (210)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2128827A (en) | 1938-03-09 | 1938-08-30 | Frank B Killian | Method and apparatus for manufacturing thin rubber articles |
CA807629A (en) | 1966-06-30 | 1969-03-04 | Eigen Edward | Lotion and detergent compositions |
JPS4838158B1 (fr) | 1970-10-05 | 1973-11-15 | ||
US3949073A (en) | 1974-11-18 | 1976-04-06 | The Board Of Trustees Of Leland Stanford Junior University | Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution |
US4060081A (en) | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
US4233360A (en) | 1975-10-22 | 1980-11-11 | Collagen Corporation | Non-antigenic collagen and articles of manufacture |
CA1073360A (fr) | 1975-10-22 | 1980-03-11 | John R. Daniels | Collagene non antigenique et articles fabriques avec ce collagene |
JPS55153711A (en) | 1979-05-19 | 1980-11-29 | Pola Chem Ind Inc | Cosmetic lotion |
US4279812A (en) | 1979-09-12 | 1981-07-21 | Seton Company | Process for preparing macromolecular biologically active collagen |
JPS6052129B2 (ja) | 1979-10-04 | 1985-11-18 | 呉羽化学工業株式会社 | 医療用コラ−ゲン繊維の製造法 |
US4424208A (en) | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4501306A (en) | 1982-11-09 | 1985-02-26 | Collagen Corporation | Automatic syringe filling system |
SE442820B (sv) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut |
US4636524A (en) | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US4605691A (en) | 1984-12-06 | 1986-08-12 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
SE8501022L (sv) | 1985-03-01 | 1986-09-02 | Pharmacia Ab | Format alster och forfarande for dess framstellning |
US4713448A (en) | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
US4642117A (en) | 1985-03-22 | 1987-02-10 | Collagen Corporation | Mechanically sheared collagen implant material and method |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
FR2608456B1 (fr) | 1986-12-18 | 1993-06-18 | Mero Rousselot Satia | Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention |
US5091171B2 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
US5385938B1 (en) | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of using glycolic acid for treating wrinkles |
FR2623167B2 (fr) | 1987-08-14 | 1992-08-07 | Genus Int | Perfectionnement aux articles munis d'articulations elastiques se rigidifiant lors de leur mise en tension |
US5017229A (en) | 1990-06-25 | 1991-05-21 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
US6174999B1 (en) | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5614587A (en) | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US5643464A (en) | 1988-11-21 | 1997-07-01 | Collagen Corporation | Process for preparing a sterile, dry crosslinking agent |
US5565519A (en) | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
SE462587B (sv) | 1988-11-30 | 1990-07-23 | Wiklund Henry & Co | Anordning vid maerkning av arbetsstycken med skrift- eller andra tecken |
JPH02215707A (ja) | 1989-02-15 | 1990-08-28 | Chisso Corp | 皮膚化粧料 |
US5137723A (en) | 1989-05-19 | 1992-08-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-Glycosyl-L-ascorbic acid, and its preparation and uses |
US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
EP0416250A3 (en) | 1989-08-01 | 1991-08-28 | The Research Foundation Of State University Of New York | N-acylurea and o-acylisourea derivatives of hyaluronic acid |
CA2023922A1 (fr) | 1989-09-05 | 1991-03-06 | James M. Curtis | Methode de fabrication d'un article implantable avec une surface a micropillier |
JP2832848B2 (ja) | 1989-10-21 | 1998-12-09 | 株式会社林原生物化学研究所 | 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途 |
US4996787A (en) * | 1990-05-29 | 1991-03-05 | Jack N. Holcomb | SigSauer pistol with concealed radio transmitter |
US5246698A (en) | 1990-07-09 | 1993-09-21 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5143724A (en) | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5492936A (en) * | 1990-11-30 | 1996-02-20 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
JP3115625B2 (ja) | 1991-03-30 | 2000-12-11 | 帝國製薬株式会社 | リドカイン含有外用貼付剤 |
US5314874A (en) | 1991-04-19 | 1994-05-24 | Koken Co., Ltd. | Intracorporeally injectable composition for implanting highly concentrated cross-linked atelocollagen |
PT632820E (pt) | 1992-02-28 | 2000-11-30 | Collagen Corp | Composicoes de colagenio homogeneizado de alta concentracao |
IT1260154B (it) | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
WO1994017227A1 (fr) | 1993-01-20 | 1994-08-04 | E.R. Squibb And Sons, Inc. | Fibres |
JP2995090B2 (ja) | 1993-03-19 | 1999-12-27 | キユー・メド・アクチエボラーグ | 組織増大のための組成物および方法 |
US5616568A (en) | 1993-11-30 | 1997-04-01 | The Research Foundation Of State University Of New York | Functionalized derivatives of hyaluronic acid |
CA2146090C (fr) | 1994-05-10 | 1998-11-24 | Mark E. Mitchell | Appareil et methode de preparation de produits dans un environnement sterile |
US5482865A (en) * | 1994-06-10 | 1996-01-09 | Associated Universities, Inc. | Apparatus and method for preparing oxygen-15 labeled water H2 [15 O] in an injectable form for use in positron emission tomography |
US5616689A (en) | 1994-07-13 | 1997-04-01 | Collagen Corporation | Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation |
AU706434B2 (en) | 1994-10-18 | 1999-06-17 | Ethicon Inc. | Injectable liquid copolymers for soft tissue repair and augmentation |
US20050186673A1 (en) | 1995-02-22 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
FR2733427B1 (fr) | 1995-04-25 | 2001-05-25 | W K Et Associes | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique |
FR2733426B1 (fr) | 1995-04-25 | 1997-07-18 | Debacker Yves | Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique |
US6214331B1 (en) | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
US5827937A (en) | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
US5571503A (en) | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
US6063405A (en) | 1995-09-29 | 2000-05-16 | L.A.M. Pharmaceuticals, Llc | Sustained release delivery system |
US6833408B2 (en) | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
IT1277707B1 (it) | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
US5980948A (en) | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
IT1287967B1 (it) | 1996-10-17 | 1998-09-10 | Fidia Spa In Amministrazione S | Preparazioni farmaceutiche per uso anestetico locale |
FR2759577B1 (fr) | 1997-02-17 | 1999-08-06 | Corneal Ind | Implant de sclerectomie profonde |
FR2759576B1 (fr) | 1997-02-17 | 1999-08-06 | Corneal Ind | Implant de sclero-keratectomie pre-descemetique |
US5935164A (en) | 1997-02-25 | 1999-08-10 | Pmt Corporaton | Laminated prosthesis and method of manufacture |
FR2764514B1 (fr) | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
US7192984B2 (en) | 1997-06-17 | 2007-03-20 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use as dermal fillers |
US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
FR2780730B1 (fr) * | 1998-07-01 | 2000-10-13 | Corneal Ind | Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique |
US6630457B1 (en) | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
IT1303738B1 (it) | 1998-11-11 | 2001-02-23 | Aquisitio S P A | Processo di reticolazione di polisaccaridi carbossilati. |
DK172900B1 (da) | 1998-12-18 | 1999-09-27 | Per Julius Nielsen | Præparat samt kit til brug ved intraoculære operationer |
GB9902652D0 (en) | 1999-02-05 | 1999-03-31 | Fermentech Med Ltd | Process |
US6767928B1 (en) | 1999-03-19 | 2004-07-27 | The Regents Of The University Of Michigan | Mineralization and biological modification of biomaterial surfaces |
US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
US6521223B1 (en) | 2000-02-14 | 2003-02-18 | Genzyme Corporation | Single phase gels for the prevention of adhesions |
US6682760B2 (en) | 2000-04-18 | 2004-01-27 | Colbar R&D Ltd. | Cross-linked collagen matrices and methods for their preparation |
KR20010096388A (ko) | 2000-04-19 | 2001-11-07 | 진세훈 | 귀두확대성형재료 및 이 재료를 이용한 귀두의 확대시술방법 |
FR2811671B1 (fr) | 2000-07-17 | 2003-02-28 | Corneal Ind | Hydrogel de polymere(s), resistant a la biodegration, preparation et utilisation a titre de support de regeneration tissulaire |
FR2811996B1 (fr) | 2000-07-19 | 2003-08-08 | Corneal Ind | Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations |
DE60133744T2 (de) | 2000-07-28 | 2009-05-14 | Anika Therapeutics, Inc., Woburn | Bioabsorbierbare kompositmaterialien aus derivatisierter hyaluronsäure |
US6620196B1 (en) | 2000-08-30 | 2003-09-16 | Sdgi Holdings, Inc. | Intervertebral disc nucleus implants and methods |
US6773723B1 (en) | 2000-08-30 | 2004-08-10 | Depuy Acromed, Inc. | Collagen/polysaccharide bilayer matrix |
US6924273B2 (en) | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
JP2004510730A (ja) | 2000-10-06 | 2004-04-08 | ヤゴテック アーゲー | 非経口的投与可能な制御放出微粒子調製物 |
KR100375299B1 (ko) | 2000-10-10 | 2003-03-10 | 주식회사 엘지생명과학 | 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법 |
US6599627B2 (en) | 2000-12-13 | 2003-07-29 | Purdue Research Foundation | Microencapsulation of drugs by solvent exchange |
US6979440B2 (en) | 2001-01-29 | 2005-12-27 | Salvona, Llc | Compositions and method for targeted controlled delivery of active ingredients and sensory markers onto hair, skin, and fabric |
US7119062B1 (en) | 2001-02-23 | 2006-10-10 | Neucoll, Inc. | Methods and compositions for improved articular surgery using collagen |
US6586493B1 (en) | 2001-03-07 | 2003-07-01 | Arizona Board Of Regents Arizona State University | Polysaccharide-based hydrogels and pre-gel blends for the same |
TW574301B (en) | 2001-05-02 | 2004-02-01 | Ind Tech Res Inst | Manufacturing method of epoxide crosslinked polysaccharides matrix |
US20050227936A1 (en) | 2001-05-18 | 2005-10-13 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA) |
BR0210722A (pt) | 2001-06-29 | 2004-07-20 | Medgraft Microtech Inc | Implantes injetáveis biodegradáveis e métodos relacionados de produção e uso |
US6749841B2 (en) | 2001-07-26 | 2004-06-15 | Revlon Consumer Products Corporation | Stabilized aqueous acidic antiperspirant compositions and related methods |
JP4230135B2 (ja) | 2001-08-21 | 2009-02-25 | 独立行政法人科学技術振興機構 | 多官能性架橋剤によって架橋したグリコサミノグリカン−コラーゲン複合体の製造法 |
US20060189516A1 (en) | 2002-02-19 | 2006-08-24 | Industrial Technology Research Institute | Method for producing cross-linked hyaluronic acid-protein bio-composites |
JP3916516B2 (ja) | 2002-06-10 | 2007-05-16 | 独立行政法人科学技術振興機構 | 硬組織−軟組織界面再生用足場材料 |
US6780366B2 (en) | 2002-08-15 | 2004-08-24 | Mentor Corporation | Drip retainer |
KR100523953B1 (ko) | 2002-08-27 | 2005-10-25 | 주식회사 엘지생명과학 | 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법 |
KR100507545B1 (ko) | 2002-09-03 | 2005-08-09 | 주식회사 엘지생명과학 | 히알루론산 유도체 및 그의 제조방법 |
US20040127932A1 (en) | 2002-09-12 | 2004-07-01 | Shah Tilak M. | Dip-molded polymeric medical devices with reverse thickness gradient, and method of making same |
DE10246340A1 (de) | 2002-10-04 | 2004-04-29 | Wohlrab, David, Dr. | Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung |
US20040101959A1 (en) | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
EP1581270A2 (fr) | 2002-12-30 | 2005-10-05 | Angiotech International Ag | Endoprotheses contenant de la soie |
TWI251596B (en) | 2002-12-31 | 2006-03-21 | Ind Tech Res Inst | Method for producing a double-crosslinked hyaluronate material |
AU2003206922A1 (en) | 2003-02-19 | 2004-09-09 | Aventis Pharmaceuticals Holdings Inc. | Composition and method for intradermal soft tissue augmentation |
EP1606009A2 (fr) | 2003-03-25 | 2005-12-21 | BioCure, Inc. | Dispositif medical de fil en hydrogel |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
AU2003901834A0 (en) | 2003-04-17 | 2003-05-01 | Clearcoll Pty Ltd | Cross-linked polysaccharide compositions |
JP2004323453A (ja) | 2003-04-25 | 2004-11-18 | Chisso Corp | 分解性ゲル及びその製造法 |
AU2003235243A1 (en) | 2003-05-13 | 2004-12-03 | Mimasu Semiconductor Industry Co., Ltd. | Wafer demounting method, wafer demounting device, and wafer demounting and transferring machine |
CA2534033A1 (fr) | 2003-07-30 | 2005-02-10 | Anteis S.A. | Matrice complexe a usage biomedical |
EP1681306B1 (fr) | 2003-10-29 | 2013-02-20 | Teijin Limited | Compose d'acide hyaluronique, son hydrogel et materiau servant a traiter les articulations |
EP1691852A2 (fr) | 2003-11-10 | 2006-08-23 | Angiotech International AG | Implants medicaux et agents inducteurs de fibrose |
US20060141049A1 (en) | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20090148527A1 (en) | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
AU2004293030A1 (en) | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Electrical devices and anti-scarring agents |
US8124120B2 (en) | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
AU2004312532B2 (en) | 2003-12-30 | 2010-05-20 | Genzyme Corporation | Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use |
DE102004002001A1 (de) | 2004-01-14 | 2005-08-11 | Reinmüller, Johannes, Dr.med. | Mittel zur Behandlung von entzündlichen Erkrankungen |
JP2007519756A (ja) | 2004-01-30 | 2007-07-19 | アンジオテック インターナショナル アーゲー | 拘縮を治療するための組成物および方法 |
US20050226936A1 (en) | 2004-04-08 | 2005-10-13 | Q-Med Ab | Method of soft tissue augmentation |
US8288362B2 (en) | 2004-05-07 | 2012-10-16 | S.K. Pharmaceuticals, Inc. | Stabilized glycosaminoglycan preparations and related methods |
US20050281880A1 (en) | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
US7651702B2 (en) | 2004-05-20 | 2010-01-26 | Mentor Corporation | Crosslinking hyaluronan and chitosanic polymers |
KR20070057767A (ko) | 2004-06-15 | 2007-06-07 | 앤드류 셴 천 | 인지질 조성물 및 이의 제조 및 사용 방법 |
WO2006020994A2 (fr) | 2004-08-13 | 2006-02-23 | Angiotech International Ag | Compositions et methodes utilisant de l'acide hyaluronique |
US20060040895A1 (en) | 2004-08-19 | 2006-02-23 | Kipling Thacker | Aesthetic use of hyaluronan |
US7414021B2 (en) | 2004-10-01 | 2008-08-19 | Vincent Carmine Giampapa | Method and composition for restoration of age related tissue loss in the face or selected areas of the body |
KR100762928B1 (ko) | 2004-10-29 | 2007-10-04 | 재단법인서울대학교산학협력재단 | 견 피브로인 나노섬유로 이루어진 부직포 형태의 골조직유도 재생용 차폐막 및 그 제조방법 |
US20060105022A1 (en) | 2004-11-15 | 2006-05-18 | Shiseido Co., Ltd. | Process for preparing crosslinked hyaluronic acid gel |
PT1817347T (pt) | 2004-11-24 | 2017-07-21 | Albumedix As | Resumo |
FR2878444B1 (fr) | 2004-11-30 | 2008-04-25 | Corneal Ind Soc Par Actions Si | Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations |
WO2006067608A1 (fr) | 2004-12-22 | 2006-06-29 | Laboratoire Medidom S.A. | Formulations aqueuses a base de hyaluronate de sodium a usage parenteral |
EP1893174A2 (fr) | 2005-05-10 | 2008-03-05 | Cytophil, Inc. | Hydrogels injectables et leurs procedes de fabrication et d'utilisation |
EP1726299A3 (fr) | 2005-05-27 | 2007-04-18 | StratoSphere Pharma AB | Noyaux et microcapsules pour l' administration parenterale et procédé pour leur fabrication |
US7491709B2 (en) | 2005-07-01 | 2009-02-17 | Wayne Carey | Treatment with hyaluronic acid |
JP5106109B2 (ja) | 2005-08-11 | 2012-12-26 | 株式会社林原 | コラーゲン産生増強剤とその用途 |
JP4982718B2 (ja) | 2005-08-31 | 2012-07-25 | 株式会社林原 | 美肌用の経口摂取用組成物 |
WO2007041627A1 (fr) | 2005-10-03 | 2007-04-12 | Pinsky Mark A | Préparations et méthodes pour soin de la peau amélioré |
CA2633978A1 (fr) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Implant bioabsorbable de derive d'acide hyaluronique destine au traitement de defauts chondraux et osteochondraux |
CA2633957A1 (fr) | 2005-12-14 | 2007-06-21 | Anika Therapeutics, Inc. | Traitements de l'arthrite et d'autres troubles musculo-squelettiques avec de l'acide hyaluronique reticule |
FR2894827B1 (fr) | 2005-12-21 | 2010-10-29 | Galderma Res & Dev | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations |
FR2895907B1 (fr) | 2006-01-06 | 2012-06-01 | Anteis Sa | Gel viscoelastique a usage dermatologique |
US20070184087A1 (en) | 2006-02-06 | 2007-08-09 | Bioform Medical, Inc. | Polysaccharide compositions for use in tissue augmentation |
US20070212385A1 (en) | 2006-03-13 | 2007-09-13 | David Nathaniel E | Fluidic Tissue Augmentation Compositions and Methods |
WO2007109069A2 (fr) | 2006-03-15 | 2007-09-27 | Surmodics, Inc. | Dérivés hydrophobes de polysaccharides biodégradables et utilisations de ceux-ci |
FR2900575B1 (fr) | 2006-05-05 | 2008-10-17 | Anteis Sa | Gel biocompatible a liberation controlee, son procede de preparation et son utilisation |
JP2009537549A (ja) | 2006-05-19 | 2009-10-29 | トラスティーズ オブ ボストン ユニバーシティ | 医療用潤滑剤およびゲルとしての新規の親水性ポリマー |
US20070298005A1 (en) | 2006-06-22 | 2007-12-27 | Marie-Josee Thibault | Injectable composition for treatment of skin defects or deformations |
WO2008003321A2 (fr) | 2006-07-07 | 2008-01-10 | Novozymes Biopolymer A/S | Compositions avec plusieurs fractions d'acide hyaluronique destinées à un usage cosmétique |
US20100035838A1 (en) | 2006-09-19 | 2010-02-11 | Geoffrey Kenneth Heber | Cross-linked polysaccharide gels |
FR2908415B1 (fr) | 2006-11-10 | 2009-01-23 | Abr Dev Sarl | Acide hyaluronique reticule et son procede de preparation |
JP5068984B2 (ja) | 2006-11-30 | 2012-11-07 | 株式会社ロイヤル | 陳列棚 |
FR2909560B1 (fr) | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
EP2121026B1 (fr) | 2006-12-11 | 2017-06-28 | CHIT2GEL Ltd. | Nouveaux mélanges injectables de chitosans formant des hydrogels |
KR100759091B1 (ko) | 2006-12-13 | 2007-09-17 | 조강선 | 피부 충전제 조성물 |
DK2107913T3 (da) | 2006-12-22 | 2012-05-21 | Croma Pharma Ges M B H | Anvendelse af thiolerede polysaccharider til vævsopbygning |
US20080188416A1 (en) | 2007-02-05 | 2008-08-07 | Freedom-2, Inc. | Tissue fillers and methods of using the same |
WO2008098019A2 (fr) | 2007-02-05 | 2008-08-14 | Carbylan Biosurgery, Inc. | Formulations polymères utilisables pour la délivrance d'agents bioactifs |
US7776840B2 (en) | 2007-02-21 | 2010-08-17 | Cutanea Life Sciences, Inc. | Methods of use of biomaterial and injectable implant containing biomaterial |
US7939578B2 (en) | 2007-02-23 | 2011-05-10 | 3M Innovative Properties Company | Polymeric fibers and methods of making |
US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
US11078262B2 (en) | 2007-04-30 | 2021-08-03 | Allergan, Inc. | High viscosity macromolecular compositions for treating ocular conditions |
EP2155212A2 (fr) | 2007-05-11 | 2010-02-24 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
WO2008148967A2 (fr) | 2007-05-11 | 2008-12-11 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
CA2687990A1 (fr) | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Collagene reticule et utilisations de ce dernier |
WO2008147817A2 (fr) | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Particules d'acide hyaluronique revêtues |
WO2008157608A1 (fr) | 2007-06-18 | 2008-12-24 | Cartlix, Inc. | Echafaudages composites pour la régénération tissulaire |
EP2182971B1 (fr) | 2007-07-27 | 2013-12-18 | Humacyte, Inc. | Compositions à base de collàgene et élastine et leurs utilisations |
US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
FR2920000B1 (fr) | 2007-08-13 | 2010-01-29 | Oreal | Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement |
CA2734577A1 (fr) | 2007-08-16 | 2009-02-26 | Carnegie Mellon University | Compositions et procedes de regulation d'inflammation |
KR100813224B1 (ko) | 2007-08-24 | 2008-03-13 | 한양대학교 산학협력단 | 단백질 약물전달용 온도 가역성 코아세르베이트 조합 겔 |
FR2920968B1 (fr) | 2007-09-14 | 2009-11-13 | Oreal | Procede cosmetique de traitement esthetique et/ou reparateur de la peau |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
US7910134B2 (en) | 2007-10-29 | 2011-03-22 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US20090143348A1 (en) | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
FR2924615B1 (fr) | 2007-12-07 | 2010-01-22 | Vivacy Lab | Hydrogel cohesif biodegradable. |
US9161970B2 (en) | 2007-12-12 | 2015-10-20 | Allergan, Inc. | Dermal filler |
ES2710498T3 (es) | 2007-12-26 | 2019-04-25 | Mark A Pinsky | Formulaciones de colágeno para la mejora del cuidado de la piel |
US20090291986A1 (en) | 2008-05-22 | 2009-11-26 | Apostolos Pappas | Composition and method of treating facial skin defect |
US20090297632A1 (en) | 2008-06-02 | 2009-12-03 | Waugh Jacob M | Device, Methods and Compositions to Alter Light Interplay with Skin |
WO2010003797A1 (fr) | 2008-07-09 | 2010-01-14 | Novozymes Biopharma Dk A/S | Acide hyaluronique pour la cicatrisation cornéenne |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
JP5722217B2 (ja) | 2008-09-02 | 2015-05-20 | アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエAllergan Holdings France S.A.S. | ヒアルロン酸および/またはその誘導体の糸、その作製方法、ならびにその使用 |
WO2010027471A2 (fr) | 2008-09-04 | 2010-03-11 | The General Hospital Corporation | Hydrogels pour l'augmentation et la réparation des cordes vocales et de tissu mou |
GB0816496D0 (en) | 2008-09-10 | 2008-10-15 | Zhao Xiaobin | Hyaluronic acid cryogel |
JP5683957B2 (ja) | 2008-09-30 | 2015-03-11 | 電気化学工業株式会社 | 光安定化された医薬組成物 |
US20100098794A1 (en) | 2008-10-17 | 2010-04-22 | Armand Gerard | Topical anti-wrinkle and anti-aging moisturizing cream |
US20100111919A1 (en) | 2008-10-31 | 2010-05-06 | Tyco Healthcare Group Lp | Delayed gelation compositions and methods of use |
WO2010053918A1 (fr) | 2008-11-05 | 2010-05-14 | Hancock Jaffe Laboratories, Inc. | Composite contenant du collagène et de l'élastine en tant qu'expanseur dermique et agent de remplissage tissulaire |
FR2938187B1 (fr) | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
JP5478631B2 (ja) | 2008-11-07 | 2014-04-23 | クロクス テクノロジーズ インコーポレイテッド | 創傷治癒のための酸化剤および光活性化剤の組み合わせ |
ITRM20080636A1 (it) | 2008-11-28 | 2010-05-29 | Univ Palermo | Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli. |
WO2010065784A2 (fr) | 2008-12-03 | 2010-06-10 | Jakk Group, Inc. | Procédés, dispositifs et compositions pour un remplissage dermique |
EP2236523B1 (fr) | 2009-03-30 | 2018-02-21 | Scivision Biotech Inc. | Procédé de production d'acide hyaluronique réticulé |
WO2010115081A2 (fr) | 2009-04-02 | 2010-10-07 | Allergan, Inc. | Hydrogels en forme de cheveu pour augmentation des tissus mous |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
EP2755630A2 (fr) | 2011-09-14 | 2014-07-23 | Allergan, Inc. | Compositions de comblement dermique pour le traitement des ridules |
US9898263B2 (en) | 2013-04-09 | 2018-02-20 | Level 3 Communications, Llc | System and method for resource-definition-oriented software generation and development |
-
2003
- 2003-04-10 FR FR0304444A patent/FR2861734B1/fr not_active Expired - Lifetime
-
2004
- 2004-04-08 BR BRPI0409762-9A patent/BRPI0409762B1/pt active IP Right Grant
- 2004-04-08 WO PCT/FR2004/000870 patent/WO2004092222A2/fr active Application Filing
- 2004-04-08 CA CA2521961A patent/CA2521961C/fr not_active Expired - Lifetime
- 2004-04-08 EP EP20100181594 patent/EP2289945B1/fr not_active Revoked
- 2004-04-08 EP EP04742458A patent/EP1611160A2/fr not_active Ceased
- 2004-04-08 US US10/552,309 patent/US7741476B2/en active Active
- 2004-04-08 EP EP20140200048 patent/EP2868669A1/fr not_active Withdrawn
- 2004-04-08 JP JP2006505785A patent/JP4827727B2/ja not_active Expired - Lifetime
- 2004-04-08 ES ES10181594.2T patent/ES2536564T3/es not_active Expired - Lifetime
-
2010
- 2010-05-18 US US12/782,488 patent/US8338388B2/en not_active Expired - Lifetime
-
2012
- 2012-08-03 US US13/566,767 patent/US8563532B2/en not_active Expired - Lifetime
-
2013
- 2013-09-12 US US14/024,916 patent/US9062130B2/en not_active Expired - Lifetime
-
2014
- 2014-11-06 US US14/535,220 patent/US20150065701A1/en not_active Abandoned
-
2016
- 2016-07-13 US US15/209,561 patent/US10080767B2/en not_active Expired - Lifetime
-
2018
- 2018-09-20 US US16/137,447 patent/US10653716B2/en not_active Expired - Lifetime
-
2020
- 2020-04-23 US US16/856,029 patent/US11045490B2/en not_active Expired - Lifetime
-
2021
- 2021-06-28 US US17/361,195 patent/US20210322460A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA949965A (en) * | 1971-12-03 | 1974-06-25 | Robert H. Marchessault | Method of preparing cross-linked starch and starch derivatives |
US4886787A (en) * | 1984-07-23 | 1989-12-12 | Pharmacia Ab | Method of preventing adhesion between body tissues, means for preventing such adhesion, and process for producing said means |
US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US5531716A (en) * | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
Non-Patent Citations (1)
Title |
---|
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; Accession number PREV200300142886 LAMAR, P. D. ET AL.: "Antifibrosis Effect of Novel Gels in Anterior Ciliary Slerotomy (ACS)" XP002265551 & LAMAR, P. D. ET AL.: "Antifibrosis Effect of Novel Gels in Anterior Ciliary Slerotomy (ACS)" ARVO ANNUAL MEETING ABSTRACT AND SEARCH PLANNER, ABSTRACT NO. 1115, vol. 2002, 2002, * |
Cited By (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8524213B2 (en) | 2003-12-30 | 2013-09-03 | Genzyme Corporation | Polymeric materials, their preparation and use |
GB2423252A (en) * | 2005-02-18 | 2006-08-23 | Engelhard Lyon | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
GB2423252B (en) * | 2005-02-18 | 2007-10-17 | Engelhard Lyon | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
US9133279B2 (en) | 2005-02-18 | 2015-09-15 | Basf Beauty Care Solutions France S.A.S. | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
JP2009536625A (ja) * | 2006-05-11 | 2009-10-15 | ゴッボ・サンドラ | ヒアルロン酸二成分混合物、その医療での使用 |
EP2489374A1 (fr) * | 2006-12-06 | 2012-08-22 | Pierre Fabre Dermo-Cosmétique | Gel d'acide hyaluronique pour injection intradermique |
EP2152329B1 (fr) | 2006-12-06 | 2017-02-15 | Merz Pharma GmbH & Co. KGaA | Gel d'acide hyaluronique pour injection intradermique |
AU2007328917B2 (en) * | 2006-12-06 | 2012-08-02 | Merz Pharma Gmbh & Co. Kgaa | Hyaluronic acid gel for intradermal injection |
CN101594892A (zh) * | 2006-12-06 | 2009-12-02 | 皮埃尔·法布尔皮肤化妆品公司 | 真皮内注射用透明质酸水凝胶 |
FR2909560A1 (fr) * | 2006-12-06 | 2008-06-13 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
US10207024B2 (en) | 2007-12-07 | 2019-02-19 | Laboratoires Vivacy | Biodegradable single-phase cohesive hydrogels |
US9919076B2 (en) | 2007-12-07 | 2018-03-20 | Laboratoires Vivacy | Biodegradable single-phase cohesive hydrogels |
US8574629B2 (en) | 2008-08-01 | 2013-11-05 | Anteis S.A. | Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume |
US10328180B2 (en) | 2008-08-04 | 2019-06-25 | Allergan Industrie, S.A.S. | Hyaluronic acid-based gels including lidocaine |
US11173232B2 (en) | 2008-08-04 | 2021-11-16 | Allergan Industrie, Sas | Hyaluronic acid-based gels including lidocaine |
US10391202B2 (en) | 2008-08-04 | 2019-08-27 | Allergan Industrie Sas | Hyaluronic acid-based gels including lidocaine |
US10485896B2 (en) | 2008-08-04 | 2019-11-26 | Allergan Industrie Sas | Hyaluronic acid-based gels including lidocaine |
US11154484B2 (en) | 2008-09-02 | 2021-10-26 | Allergan Holdings France S.A.S. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US9861570B2 (en) | 2008-09-02 | 2018-01-09 | Allergan Holdings France S.A.S. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US9228027B2 (en) | 2008-09-02 | 2016-01-05 | Allergan Holdings France S.A.S. | Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
EP2676658A1 (fr) | 2008-11-07 | 2013-12-25 | Anteis SA | Composition injectable à base d'acide hyaluronique, de polyol(s) et de lidocaïne, stérilisée à la chaleur |
US8455465B2 (en) | 2008-11-07 | 2013-06-04 | Anteis S.A. | Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
EP2676658B1 (fr) | 2008-11-07 | 2015-09-16 | Anteis SA | Composition injectable à base d'acide hyaluronique, de polyol(s) et de lidocaïne, stérilisée à la chaleur |
WO2010052430A2 (fr) | 2008-11-07 | 2010-05-14 | Anteis S.A. | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaïne, sterilisee a la chaleur |
WO2010115081A3 (fr) * | 2009-04-02 | 2012-04-12 | Allergan, Inc. | Hydrogels en forme de cheveu pour augmentation des tissus mous |
EP2289522A1 (fr) * | 2009-08-14 | 2011-03-02 | Holy Stone Healthcare Co.,Ltd. | Utilisation d'acide hyaluronique pour le traitement d'ulcers gastro-duodenaux |
ES2362587A1 (es) * | 2009-12-24 | 2011-07-08 | Laboratorios Viñas S.A. | "toallita impregnada con una composición farmacéutica que comprende acido hialurónico, composición farmacéutica que comprende ácido hialurónico y usos correspondientes.". |
EP2404619A1 (fr) * | 2010-07-05 | 2012-01-11 | Alain Villette | Composition injectable comprenant un médicament injectable et un gel |
WO2012032151A3 (fr) * | 2010-09-09 | 2012-08-30 | Altergon S.A. | Complexes hybrides coopératifs d'acide hyaluronique |
ITMI20101635A1 (it) * | 2010-09-09 | 2012-03-10 | Ibsa Inst Biochimique Sa | Complessi cooperativi ibridi di acido ialuronico |
EP2637710B1 (fr) | 2010-11-08 | 2017-04-05 | Allergan Industrie, SAS | Formulations à base d'acide hyaluronique |
WO2013053457A1 (fr) | 2011-10-12 | 2013-04-18 | Regenyal Laboratories S.R.L. | Synthèse d'un gel multiphasique injectable contenant de l'acide hyaluronique monophasique libre et réticulé et de l'acide hyaluronique biphasique en association avec de l'hydroxyapatite et un inhibiteur de l'hyaluronidase microencapsulé |
US9314530B2 (en) | 2012-06-13 | 2016-04-19 | Laboratoires Vivacy | Composition, in aqueous medium, that comprises at least a hyaluronic acid and at least an hydrosoluble salt of sucrose octasulfate |
US9402799B2 (en) | 2012-08-29 | 2016-08-02 | Laboratories Vivacy | Sterilized composition comprising at least one hyaluronic acid and magnesium ascorbyl phosphate |
US10058499B2 (en) | 2012-08-29 | 2018-08-28 | Laboratoires Vivacy | Sterilized composition comprising at least one hyaluronic acid and magnesium ascorbyl phosphate |
EP3797757A1 (fr) | 2012-08-29 | 2021-03-31 | Laboratoires Vivacy | Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium |
EP3007737B1 (fr) | 2013-06-11 | 2017-10-18 | Anteis SA | Procédé de réticulation de l'acide hyaluronique, procédé de préparation d'un hydrogel injectable, hydrogel obtenu et utilisation de l'hydrogel obtenu |
US9155757B2 (en) | 2013-10-07 | 2015-10-13 | Laboratoires Vivacy | Methods and kits for treating vaginal and vulvar vestibule mucosa disorders |
EP3173086A1 (fr) | 2013-12-23 | 2017-05-31 | Laboratoires Vivacy | Compositions d'acide hyaluronique comprenant de la mépivacaïne |
US12011500B2 (en) | 2015-02-09 | 2024-06-18 | Allergan Industrie, Sas | Compositions and methods for improving skin appearance |
US11260015B2 (en) | 2015-02-09 | 2022-03-01 | Allergan Industrie, Sas | Compositions and methods for improving skin appearance |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
WO2016180904A1 (fr) | 2015-05-11 | 2016-11-17 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
US10588922B2 (en) | 2015-06-24 | 2020-03-17 | Kylane Laboratoires Sa | Method for preparing an injectable cross-linked hydrogel, hydrogel obtained; and use of the obtained hydrogel |
US10500225B2 (en) | 2015-12-07 | 2019-12-10 | Kh Medtech Sárl | Injectable composition; method for preparing said composition; use of said composition |
WO2017098091A1 (fr) | 2015-12-07 | 2017-06-15 | Tauzin Bénédicte Vincente | Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition |
WO2017102001A1 (fr) | 2015-12-16 | 2017-06-22 | Vplus International Sa | Composition d'acide hyaluronique pour injections peniennes |
WO2017140958A1 (fr) | 2016-02-15 | 2017-08-24 | Tauzin Bénédicte Vincente | Composition injectable; procédé de préparation de ladite composition; utilisation de ladite composition |
EP3315130A1 (fr) | 2016-10-28 | 2018-05-02 | Laboratoires Vivacy | Composition a base d'acide hyaluronique comprenant de la mepivacaïne |
WO2018220283A1 (fr) | 2017-05-29 | 2018-12-06 | Kh Medtech Sarl | Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine |
WO2018220288A1 (fr) | 2017-05-29 | 2018-12-06 | Tauzin Benedicte Vincente | Composition injectable stérile contenant de l'acide hyaluronique réticule et de l'articaine |
WO2021260145A1 (fr) | 2020-06-24 | 2021-12-30 | Laboratoires Vivacy | Procede d'incorporation de composes organiques en solution au sein d'un hydrogel |
FR3111903A1 (fr) | 2020-06-24 | 2021-12-31 | Laboratoires Vivacy | Procede d’incorporation de composes organiques en solution au sein d’un hydrogel |
WO2022038156A1 (fr) | 2020-08-20 | 2022-02-24 | Laboratoires Vivacy | Procede d'evaluation des caracteristiques rheologiques d'un gel |
FR3113522A1 (fr) | 2020-08-20 | 2022-02-25 | Laboratoires Vivacy | procédé d’évaluation des caractéristiques rhéologiques d’un gel |
WO2023187131A1 (fr) | 2022-03-30 | 2023-10-05 | Laboratoires Vivacy | Emulsion comprenant un hydrogel et de la graisse ou un derive de graisse |
FR3135399A1 (fr) | 2022-03-30 | 2023-11-17 | Laboratoires Vivacy | émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse |
Also Published As
Publication number | Publication date |
---|---|
FR2861734B1 (fr) | 2006-04-14 |
CA2521961C (fr) | 2013-07-23 |
US20120295870A1 (en) | 2012-11-22 |
US8338388B2 (en) | 2012-12-25 |
US11045490B2 (en) | 2021-06-29 |
US20200246375A1 (en) | 2020-08-06 |
US10080767B2 (en) | 2018-09-25 |
US20150065701A1 (en) | 2015-03-05 |
EP2289945B1 (fr) | 2015-03-04 |
US20140011990A1 (en) | 2014-01-09 |
EP2868669A1 (fr) | 2015-05-06 |
US10653716B2 (en) | 2020-05-19 |
ES2536564T3 (es) | 2015-05-26 |
EP1611160A2 (fr) | 2006-01-04 |
US20210322460A1 (en) | 2021-10-21 |
BRPI0409762B1 (pt) | 2021-10-13 |
US20060194758A1 (en) | 2006-08-31 |
US8563532B2 (en) | 2013-10-22 |
US20160317571A1 (en) | 2016-11-03 |
FR2861734A1 (fr) | 2005-05-06 |
US20190022130A1 (en) | 2019-01-24 |
CA2521961A1 (fr) | 2004-10-28 |
BRPI0409762A (pt) | 2006-05-09 |
EP2289945A1 (fr) | 2011-03-02 |
US9062130B2 (en) | 2015-06-23 |
US20100226988A1 (en) | 2010-09-09 |
US7741476B2 (en) | 2010-06-22 |
JP4827727B2 (ja) | 2011-11-30 |
WO2004092222A3 (fr) | 2004-12-09 |
JP2006522851A (ja) | 2006-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1611160A2 (fr) | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; | |
EP1303542B3 (fr) | Preparation d'acide hyaluronique reticule et de son hydrogel, les produits obtenus et leurs utilisations. | |
CN109734825B (zh) | 用于制造成形的交联的透明质酸产物的方法 | |
WO1996033751A1 (fr) | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique | |
CA2708023A1 (fr) | Hydrogel cohesif monophasique biodegradable | |
FR2733427A1 (fr) | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique | |
EP1091775A1 (fr) | Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique | |
FR2983483A1 (fr) | Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles | |
Fatimi et al. | Gelation studies of a cellulose-based biohydrogel: The influence of pH, temperature and sterilization | |
JP2022527503A (ja) | 複数の形態のヒアルロン酸を含む注射可能で均質なゲルおよびその製造方法 | |
EP3956386A1 (fr) | Procede de reticulation d'un polymere | |
JP2024509534A (ja) | ポリマーをベースとする植込み型又は注入型生成物及びそれらの調製方法 | |
FR3113522A1 (fr) | procédé d’évaluation des caractéristiques rhéologiques d’un gel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006194758 Country of ref document: US Ref document number: 2521961 Country of ref document: CA Ref document number: 2006505785 Country of ref document: JP Ref document number: 10552309 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004742458 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004742458 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0409762 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 10552309 Country of ref document: US |